Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antigen Specificity Enhances Disease Control by Tregs in Vitiligo
Zhussipbek Mukhatayev, Emilia R. Dellacecca, Cormac Cosgrove, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Update on the pathogenesis of vitiligo
Helena Zenedin Marchioro, Caio César Silva de Castro, Vinicius M. Fava, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 4, pp. 478-490
Open Access | Times Cited: 83
CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
Motahareh Arjomandnejad, Acadia L. Kopec, Allison M. Keeler
Biomedicines (2022) Vol. 10, Iss. 2, pp. 287-287
Open Access | Times Cited: 70
Advances in vitiligo: Update on therapeutic targets
Yifei Feng, Yan Lu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 57
New cell sources for CAR-based immunotherapy
Marzieh Mazinani, Fatemeh Rahbarizadeh
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Frontiers in CAR-T cell therapy for autoimmune diseases
Yan-Ruide Li, Zibai Lyu, Yuning Chen, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 9, pp. 839-857
Open Access | Times Cited: 9
Patho-immunological mechanisms of vitiligo: the role of the innate and adaptive immunities and environmental stress factors
Safa Faraj, E. Helen Kemp, David J. Gawkrodger
Clinical & Experimental Immunology (2021) Vol. 207, Iss. 1, pp. 27-43
Open Access | Times Cited: 52
Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges
Tobias Riët, Markus Chmielewski
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Vitiligo: advances in pathophysiology research and treatment development
Zhussipbek Mukhatayev, I. Caroline Le Poole
Trends in Molecular Medicine (2024) Vol. 30, Iss. 9, pp. 844-862
Closed Access | Times Cited: 7
Engineered antigen-specific regulatory T cells for autoimmune skin conditions
Zhussipbek Mukhatayev, Yekaterina O. Ostapchuk, Deyu Fang, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 3, pp. 102761-102761
Open Access | Times Cited: 38
CAR Treg: A new approach in the treatment of autoimmune diseases
Seyedeh Ameneh Beheshti, Karim Shamsasenjan, Majid Ahmadi, et al.
International Immunopharmacology (2021) Vol. 102, pp. 108409-108409
Closed Access | Times Cited: 34
Regulatory T-cell therapy approaches
Oliver McCallion, Merve Bilici, Joanna Hester, et al.
Clinical & Experimental Immunology (2022) Vol. 211, Iss. 2, pp. 96-107
Open Access | Times Cited: 25
Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients
Prashant S. Giri, Ankit H. Bharti, Rasheedunnisa Begum, et al.
Immunology (2022) Vol. 167, Iss. 3, pp. 314-327
Open Access | Times Cited: 23
Cell-based therapies for rheumatoid arthritis: opportunities and challenges
Yujing Li, Zhu Chen
Therapeutic Advances in Musculoskeletal Disease (2022) Vol. 14
Open Access | Times Cited: 23
Meta-Analysis of Alterations in Regulatory T Cells’ Frequency and Suppressive Capacity in Patients with Vitiligo
Prashant S. Giri, Jahanvi Mistry, Mitesh Dwivedi
Journal of Immunology Research (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 22
Human OX40L–CAR-T regs target activated antigen-presenting cells and control T cell alloreactivity
Xianliang Rui, Francesca Alvarez‐Calderon, Holly Wobma, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 769
Closed Access | Times Cited: 5
The role of aryl hydrocarbon receptor in vitiligo: a review
Yiting Li, Yibin Zeng, Zile Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Eleonora Pinto, Lisa A. Lione, Mirco Compagnone, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report
Xiaoming Mao, Weihua Wang
World Journal of Clinical Cases (2025) Vol. 13, Iss. 14
Closed Access
Advances in engineered T cell immunotherapy for autoimmune and other non-oncological diseases
Qiaolin Huang, Xiaojian Zhu, Yicheng Zhang
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Tonic signaling in CAR-T therapy: the lever long enough to move the planet
Yuwei Huang, Haopeng Wang
Frontiers of Medicine (2025)
Closed Access
Functional heterogeneity of human skin‐resident memory T cells in health and disease
Johanna Strobl, Muzlifah Haniffa
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 104-119
Open Access | Times Cited: 12
Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection
Bo Xie, Yuqi Zhu, Yuqing Shen, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 3, pp. 189-206
Closed Access | Times Cited: 11
Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation
Ilse Gille, Frans H.J. Claas, Geert W. Haasnoot, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
CARs: a new approach for the treatment of autoimmune diseases
Yeting Sun, Yeshuang Yuan, Bo Zhang, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 4, pp. 711-728
Open Access | Times Cited: 17
The potential of regulatory T cell-based therapies for alopecia areata
Sheng Wan, Wen Xu, Bo Xie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top